Literature DB >> 17053959

The significance of the furosemide test for predicting ascites control by diuretics in cirrhotics: a comparison with volume expansion and octreotide infusion.

Pierluigi Toniutto1, Mario Pirisi, Carlo Fabris, Luca Apollonio, Kalliopi Sereti, Ettore G Bartoli.   

Abstract

To verify prospectively the usefulness of the furosemide-induced natriuresis test in predicting ascites control by medical treatment, 15 stable cirrhotics (9 male) with ascites were studied. Sodium excretion was measured after this test and after volume expansion with saline associated with intravenous infusion of octreotide; 6 months later, response to medical treatment was rated as good (N=9) or poor (N=6). Patients with poor ascites control had lower sodium excretion with the furosemide-induced natriuresis test (median, 88 vs 201 mmol; P < 0.01). Poor control was observed in four of four patients with sodium excretion < or =125 mmol, and good control in six of six patients with sodium excretion >175 mmol (P < 0.002). Volume expansion was followed by limited natriuresis (median, 20 mmol), in inverse relationship with plasma active renin concentration (P < 0.001). In conclusion, long-term ascites control is well predicted by the furosemide-induced natriuresis test.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053959     DOI: 10.1007/s10620-005-9072-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Management of adult patients with ascites due to cirrhosis.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2004-03       Impact factor: 17.425

Review 2.  The site of action of furosemide.

Authors:  G Romano; G Favret; E Federico; E Bartoli
Journal:  Pharmacol Res       Date:  1998-05       Impact factor: 7.658

3.  Effects of long-term administration of octreotide on sodium retention and atrial natriuretic peptide in carbon tetrachloride-induced cirrhotic rats.

Authors:  S S Wang; F Y Lee; S L Wu; C M Hwu; C H Chien; S D Lee; Y T Tsai; Y Chao; C C Chen; P S Wang
Journal:  J Hepatol       Date:  1997-05       Impact factor: 25.083

4.  Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.

Authors:  S Møller; K Brinch; J H Henriksen; U Becker
Journal:  J Hepatol       Date:  1997-05       Impact factor: 25.083

5.  The pharmacokinetics of octreotide in cirrhosis and in healthy man.

Authors:  L H Ottesen; A Flyvbjerg; P Jakobsen; F Bendtsen
Journal:  J Hepatol       Date:  1997-05       Impact factor: 25.083

6.  The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man.

Authors:  A K Kubba; H Dallal; G H Haydon; P C Hayes; K R Palmer
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

7.  Urinary thiamine excretion in the rat: effects of furosemide, other diuretics, and volume load.

Authors:  A Lubetsky; J Winaver; H Seligmann; D Olchovsky; S Almog; H Halkin; D Ezra
Journal:  J Lab Clin Med       Date:  1999-09

8.  Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.

Authors:  M Guevara; P Ginès; G Fernández-Esparrach; P Sort; J M Salmerón; W Jiménez; V Arroyo; J Rodés
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

Review 9.  Gender-specific implications for cardiovascular medication use in the elderly optimizing therapy for older women.

Authors:  Janice B Schwartz
Journal:  Cardiol Rev       Date:  2003 Sep-Oct       Impact factor: 2.644

10.  Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.

Authors:  R M Pérez-Ayuso; V Arroyo; R Planas; J Gaya; F Bory; A Rimola; F Rivera; J Rodés
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

View more
  1 in total

1.  Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study.

Authors:  Haruki Uojima; Hisashi Hidaka; Tsuyoshi Nakayama; Ji Hyun Sung; Chikamasa Ichita; Shinnosuke Tokoro; Sakue Masuda; Akiko Sasaki; Kazuya Koizumi; Hideto Egashira; Makoto Kako
Journal:  World J Gastroenterol       Date:  2017-12-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.